| Prev Close | 6.52 |
| Open | 6.51 |
| Day Low/High | 6.39 / 6.59 |
| 52 Wk Low/High | 2.97 / 8.44 |
| Volume | 445.68K |
Latest News
CannaStocks2019 Q1 Investor Conference To Be Held On Wednesday May 15th At OTC Markets Group
NEW YORK, May 6, 2019 /PRNewswire/ -- CannaStocks2019 today announced that its Q1 Investor Conference will be held at the OTC Markets Group offices in New York on May 15 th.
9 Speculative Plays for Investors Wanting Cannabis Exposure
Five top marijuana stocks and four CBD plays in this speculative space.
The Future of Cannabis: Edibles & Oil Based Products
When it comes to products related to cannabis consumption, a rich universe of options continues to scale up around oils and edibles.
Organigram Announces Conversion Of $98 Million Debentures Into Common Shares
MONCTON, NB, Feb. 27, 2019 /PRNewswire/ - Organigram Holdings Inc.
Organigram Signs Quebec Letter Of Intent; Now In All 10 Canadian Provinces
Supply agreement cements Organigram's position as a national leader in Canada's recreational cannabis marketplace MONCTON, NB, Feb.
Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys
Analyst Owen Bennett also says the market could rise to as high as $130 billion in 10 years.
Organigram Ranked As 4th Best Performing Stock On The OTCQX® Best Market For 2018
MONCTON, NB, Feb. 20, 2019 /PRNewswire/ - Organigram Holdings Inc.
Investing Ideas for Extraction and Vape
Valens GroWorks gains traction in rapidly growing space.
Organigram Signs Multi-Year Cannabis Extraction Agreement With Valens GroWorks Corp.
Partnership supports Organigram's large-scale extraction and production strategy MONCTON, NB, Jan.
Organigram Appoints Amy Schwalm Vice President, Investor Relations
New Appointment Brings Senior Investor Relations Experience from Industry Leaders in Communications and Mining Sectors MONCTON, NB, Jan.
How to Invest in Cannabis - In Its Many Forms
As cannabis becomes more and more legal, investors have started to wonder what that means for them.
Out-of-Stock Levels Are High for Recreational Cannabis in Canada
An early look at the market shows supply is finding it tough to keep up with demand.
What Are the Side Effects of Marijuana? Experts Explain in 2018
As cannabis becomes increasingly legalized in a recreational and medicinal capacity, what actually are the side effects of marijuana? Experts told TheStreet the things you need to know about how the plant affects you.
What is THC? Experts Weigh in on Benefits and Effects
THC is the psychoactive ingredient in marijuana that produces the feeling of being high. But, THC also has other applications that include health benefits and some side effects.
Echelon Initiates Coverage on Organigram
Echelon initiates coverage on Organigram, a cannabis company.
Canopy Growth Leads Cannabis Debt Bonanza
A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29.
Fund Manager High On Marijuana, Zinc as Shelters in Pullback
Growth is almost guaranteed in these two areas, says James McDonald of Index Strategy Advisors.
How Investors Can Generate Higher Returns From the January Effect
The outperformance of stocks in January has been linked to the sale of assets that have performed poorly and year-end tax selling, but a different market could occur in 2017.
